Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
11.29
-0.20 (-1.74%)
At close: Aug 25, 2026, 4:00 PM EDT
11.18
-0.11 (-0.97%)
Pre-market: Aug 26, 2026, 5:07 AM EDT

Cellebrite DI Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
514.29475.68401.2325.11270.65246.25
Revenue Growth
17.76%18.56%23.41%20.12%9.91%26.34%
Cost of Revenue
87.6375.1762.5953.2350.7542.56
Gross Profit
426.66400.5338.61271.88219.91203.69
Selling, General & Admin
240.97220.15183.29154.26138.24124.33
Research & Development
129.82113.8898.4284.3980.6265.54
Operating Expenses
370.79334.02281.7238.64218.86189.87
Operating Income
55.8666.4856.9133.241.0413.82
Interest & Investment Income
22.8123.9418.2310.582.030.85
Currency Exchange Gain (Loss)
-1.640.74-1.350.210.85-0.19
Other Non Operating Income (Expenses)
-1.65-0.48-349.77-119.58116.8567.83
EBT Excluding Unusual Items
75.3890.68-275.98-75.56120.7682.31
Pretax Income
75.3890.68-275.98-75.56120.7682.31
Income Tax Expense
16.6212.357.025.54-0.0510.91
Net Income
58.7678.33-283.01-81.1120.8171.4
Preferred Dividends & Other Adjustments
0.510.51--4.690.96
Net Income to Common
58.2577.81-283.01-81.1116.1170.43
Net Income Growth
----64.85%-
Shares Outstanding (Basic)
246242209190183144
Shares Outstanding (Diluted)
251250209190195162
Shares Change
9.33%19.30%10.16%-2.68%20.96%30.59%
EPS (Basic)
0.240.32-1.35-0.430.640.49
EPS (Diluted)
0.230.31-1.35-0.430.590.44
EPS Growth
----34.09%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
144.17160.32123.6196.8313.6830.94
Free Cash Flow Per Share
0.570.640.590.510.070.19
Gross Margin
82.96%84.20%84.40%83.63%81.25%82.72%
Operating Margin
10.86%13.98%14.18%10.22%0.39%5.61%
Profit Margin
11.33%16.36%-70.54%-24.95%42.90%28.60%
Free Cash Flow Margin
28.03%33.70%30.81%29.78%5.05%12.57%
EBITDA
78.4378.3567.5143.2510.2420.9
EBITDA Margin
15.25%16.47%16.83%13.30%3.78%8.49%
D&A For EBITDA
22.5611.8710.6110.019.197.07
EBIT
55.8666.4856.9133.241.0413.82
EBIT Margin
10.86%13.98%14.18%10.22%0.39%5.61%
Effective Tax Rate
22.05%13.62%---13.25%
Revenue as Reported
514.29475.68401.2325.11270.65246.25
SEC Filings: 10-K · 10-Q